SLU-PP-332 is an experimental compound researched for its ability to mimic the metabolic effects of exercise by activating estrogen-related receptors (ERRα, ERRβ, and ERRγ). Studies suggest it may enhance mitochondrial function, increase energy expenditure, and promote fatty acid oxidation, potentially supporting endurance, metabolic health, and muscle performance in preclinical models.